6,6′-Bieckol, isolated from marine alga Ecklonia cava, suppressed LPS-induced nitric oxide and PGE 2 production and inflammatory cytokine expression in macrophages: The inhibition of NFκB

International Immunopharmacology

Volumn 12, Issue 3, 2012, Pages 510-517

  Yang, Yeong In ^a   Shin, Hyeon Cheol ^b   Kim, Seong Ho ^b   Park, Woong Yang ^c   Lee, Kyung Tae ^a   Choi, Jung Hye ^a  

^a Kyung Hee University   (South Korea)

^b Botamedi Research Center   (United States)

^c Seoul National University College of Medicine   (South Korea)

Author keywords

6,6 Bieckol; COX 2; Ecklonia cava; Inflammation; iNOS; NF B

Indexed keywords

6,6' BIECKOL; ANTIINFLAMMATORY AGENT; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; NITRIC OXIDE; PROSTAGLANDIN E2; PROTEIN P50; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; 6,6'-BIECKOL; CYTOKINE; DIOXIN; RNA;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BROWN ALGA; CELL SURVIVAL; CELL VIABILITY; CHROMATIN; CONCENTRATION (PARAMETERS); CYTOPLASM; CYTOTOXICITY; DOWN REGULATION; ECKLONIA CAVA; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN BINDING; PROTEIN EXPRESSION; UPREGULATION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL LINE; CELL NUCLEUS; CHEMISTRY; CHROMATIN IMMUNOPRECIPITATION; DRUG ANTAGONISM; DRUG EFFECT; GENETIC TRANSFECTION; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; PERITONEUM MACROPHAGE; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL LINE; CELL NUCLEUS; CELL SURVIVAL; CHROMATIN IMMUNOPRECIPITATION; CYCLOOXYGENASE 2; CYTOKINES; DINOPROSTONE; DIOXINS; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PHAEOPHYTA; REAL-TIME POLYMERASE CHAIN REACTION; RNA; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84857356346     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2012.01.005     Document Type: Article

References (26)

1. T. Lawrence, D.A. Willoughby, and D.W. Gilroy Anti-inflammatory lipid mediators and insights into the resolution of inflammation Nat Rev Immunol 2 2002 787 795 (Pubitemid 37328718)
2. K.S. Lau, R.W. Grange, E. Isotani, I.H. Sarelius, K.E. Kamm, and P.L. Huang nNOS and eNOS modulate cGMP formation and vascular response in contracting fast-twitch skeletal muscle Physiol Genomics 2 2000 21 27
3. R. Zamora, Y. Vodovotz, and T.R. Billiar Inducible nitric oxide synthase and inflammatory diseases Mol Med 6 2000 347 373
4. Y.J. Kang, U.R. Mbonye, C.J. DeLong, M. Wada, and W.L. Smith Regulation of intracellular cyclooxygenase levels by gene transcription and protein degradation Prog Lipid Res 46 2007 108 125 (Pubitemid 46661865)
5. B. Hinz, and K. Brune Cyclooxygenase-2-10 years later J Pharmacol Exp Ther 300 2002 367 375
6. S.M. Prescott, and F.A. Fitzpatrick Cyclooxygenase-2 and carcinogenesis Biochim Biophys Acta 1470 2000 M69 M78
7. H.S. Kang, H.Y. Chung, J.Y. Kim, B.W. Son, H.A. Jung, and J.S. Choi Inhibitory phlorotannins from the edible brown alga Ecklonia stolonifera on total reactive oxygen species (ROS) generation Arch Pharm Res 27 2004 194 198
8. K. Nagayama, Y. Iwamura, T. Shibata, I. Hirayama, and T. Nakamura Bactericidal activity of phlorotannins from the brown alga Ecklonia kurome J Antimicrob Chemother 50 2002 889 893 (Pubitemid 36032809)
9. W.K. Jung, Y.W. Ahn, S.H. Lee, Y.H. Choi, S.K. Kim, and S.S. Yea Ecklonia cava ethanolic extracts inhibit lipopolysaccharide-induced cyclooxygenase-2 and inducible nitric oxide synthase expression in BV2 microglia via the MAP kinase and NF-kappaB pathways Food Chem Toxicol 47 2009 410 417
10. H.C. Shin, H.J. Hwang, K.J. Kang, and B.H. Lee An antioxidative and antiinflammatory agent for potential treatment of osteoarthritis from Ecklonia cava Arch Pharm Res 29 2006 165 171 (Pubitemid 43352466)
11. Y. Fukuyama, M. Kodama, I. Miura, Z. Kinzyo, M. Kido, and H. Mori Structure of an anti-plasmin inhibitor, eckol, isolated from the brown alga Ecklonia kurome Okamura and inhibitory activities of its derivatives on plasma plasmin inhibitors Chem Pharm Bull(Tokyo) 37 1989 349 353 (Pubitemid 19082572)
12. M.J. Joe, S.N. Kim, H.Y. Choi, W.S. Shin, G.M. Park, and D.W. Kang The inhibitory effects of eckol and dieckol from Ecklonia stolonifera on the expression of matrix metalloproteinase-1 in human dermal fibroblasts Biol Pharm Bull 29 2006 1735 1739
13. M. Artan, Y. Li, F. Karadeniz, S.H. Lee, M.M. Kim, and S.K. Kim Anti-HIV-1 activity of phloroglucinol derivative, 6,6′-bieckol, from Ecklonia cava Bioorg Med Chem 16 2008 7921 7926
14. H. Hwang, T. Chen, R.G. Nines, H.C. Shin, and G.D. Stoner Photochemoprevention of UVB-induced skin carcinogenesis in SKH-1 mice by brown algae polyphenols Int J Cancer 119 2006 2742 2749 (Pubitemid 44846224)
15. H.J. An, M.J. Seo, I.Y. Choi, R.K. Park, S. Jeong, and J.Y. Lee Induction of nitric oxide & tumour necrosis factor-alpha by Psoralea corylifolia Indian J Med Res 128 2008 752 758
16. H. Nisizawa KN, R. Kikuchi, and T. Watamaba The main seaweed foods in Japan Hydrobiologia 151/152 1987 5 29
17. Y. Zou, Z.J. Qian, Y. Li, M.M. Kim, S.H. Lee, and S.K. Kim Antioxidant effects of phlorotannins isolated from Ishige okamurae in free radical mediated oxidative systems J Agric Food Chem 56 2008 7001 7009
18. Y. Li, Z.J. Qian, B. Ryu, S.H. Lee, M.M. Kim, and S.K. Kim Chemical components and its antioxidant properties in vitro: an edible marine brown alga, Ecklonia cava Bioorg Med Chem 17 2009 1963 1973
19. M.J. Ahn, K.D. Yoon, S.Y. Min, J.S. Lee, J.H. Kim, and T.G. Kim Inhibition of HIV-1 reverse transcriptase and protease by phlorotannins from the brown alga Ecklonia cava Biol Pharm Bull 27 2004 544 547 (Pubitemid 41701842)
20. A.R. Kim, T.S. Shin, M.S. Lee, J.Y. Park, K.E. Park, and N.Y. Yoon Isolation and identification of phlorotannins from Ecklonia stolonifera with antioxidant and anti-inflammatory properties J Agric Food Chem 57 2009 3483 3489
21. I.B. McInnes, and G. Schett Cytokines in the pathogenesis of rheumatoid arthritis Nat Rev Immunol 7 2007 429 442 (Pubitemid 46834849)
22. N. Mukaida The roles of cytokine receptors in diseases Rinsho Byori 48 2000 409 415
23. Y. Yamamoto, and R.B. Gaynor Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer J Clin Invest 107 2001 135 142 (Pubitemid 32096826)
24. S. Mocellin, F. Marincola, C.R. Rossi, D. Nitti, and M. Lise The multifaceted relationship between IL-10 and adaptive immunity: putting together the pieces of a puzzle Cytokine Growth Factor Rev 15 2004 61 76 (Pubitemid 38121291)
25. R.W. Kinne, R. Brauer, B. Stuhlmuller, E. Palombo-Kinne, and G.R. Burmester Macrophages in rheumatoid arthritis Arthritis Res 2 2000 189 202 (Pubitemid 32223726)
26. Y.J. Surh, K.S. Chun, H.H. Cha, S.S. Han, Y.S. Keum, and K.K. Park Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation Mutat Res 480-481 2001 243 268 (Pubitemid 32744832)